MyAverix Finance
SHG · Healthcare
Autobio Diagnostics Co Ltd (603658)
Medical Devices
Autobio Diagnostics Co Ltd (603658) is listed on SHG in the Healthcare sector. Industry: Medical Devices. As of 2026-03-29, reported market cap is $19.07B, P/E ratio is 17.38, net margin is 26.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603658
Autobio Diagnostics Co Ltd (603658) — FAQ
What is Autobio Diagnostics Co Ltd's market cap?
Autobio Diagnostics Co Ltd (603658) has a reported market cap of $19.07B (data as of 2026-03-29).
What is 603658's P/E ratio?
The price-to-earnings (P/E) ratio for Autobio Diagnostics Co Ltd (603658) is 17.38 (data as of 2026-03-29).
Does Autobio Diagnostics Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Autobio Diagnostics Co Ltd (603658). Check the MyAverix Finance app for the latest dividend data.
What sector is Autobio Diagnostics Co Ltd in?
Autobio Diagnostics Co Ltd (603658) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 603658 listed on?
603658 is listed on SHG.
What is Autobio Diagnostics Co Ltd's net margin?
Autobio Diagnostics Co Ltd (603658) reports a net margin of 26.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.